Biora Therapeutics Inc (BIOR) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access BIOR Annual Balance Sheets →
Reviewing balance sheet figures over time helps illustrate how Biora Therapeutics Inc manages its resources, obligations, and shareholder equity.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Sep 30 2024) (Jun 30 2024) (Mar 31 2024) (Dec 31 2023)
Assets
Cash & cash equivalent21.91
Cash & Short-term Investments21.00
Accounts receivable3.32
Income Taxes Receivable, Current NO0.00
Other Current Assets29.96
Prepaid Expense And Other Assets Current0.87
Total Current Assets56.07
Equipment/Property/Plant Net19.15
Goodwill net0.00
Deferred, Prepaid and Other Assets, Noncurrent22.95
Other Assets, Noncurrent2.21
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents3.20
Operating Lease Right Of Use Asset1.01
Total Assets100.38
Liabilities
Accounts Payable, Current AC2.49
Accrued Liabilities, Current AC1.43
Derivative Liability, Current DE0.00
Short-term Debt0.41
Other Liabilities, Current34.35
Total Current Liabilities38.69
Long-term Debt Convertible0.00
Total Long-term Debt0.00
Derivative Liability, Noncurrent DE0.00
Other liabilities, Noncurrent27.64
Accrued Expenses And Other Liabilities Current19.72
Related Party Senior Secured Convertible Notes Non Current-
Total Liabilities66.33
Stockholders' Equity
Treasury Stock Common Value-19.08
Common Stock Value0.11
Additional Paid In Capital Common Stock472.37
Retained Earnings / Accumulated Deficit-438.44
Defined Benefit Plan and Other0.00
Other Equity0.00
Common Stockholder's Equity34.05
Total Stockholder's Equity34.05
Liabilities & Stockholder's Equity100.38
4 historic quarters locked

Sign in to unlock the full Biora Therapeutics Inc balance sheet history.

About Biora Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20240930)
  • Filed with the SEC: November 14, 2024
  • Source: bior-20240930.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0000950170-24-127060

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.